Leading Biotechnology Company Selects Labtronics’ LimsLink as the Integration Solution for their Global Product Data Management System
Labtronics Inc., a world leader in providing innovative laboratory data integration and management solutions, today announced that Genzyme Corporation has chosen Labtronics’ industry-leading LimsLink solution to provide the integration capabilities required to achieve their goal of creating a Global Product Data Management solution.
Genzyme is one of the world’s top biotechnology companies, and its rapid growth has resulted in many regulated products both in the marketplace and in their pipeline. This has created an increase in the amount of product data that they need to capture, process and archive by several orders of magnitude over the past few years. Genzyme recognized that they needed to ensure that these large volumes of product data could be managed effectively and efficiently while also complying with the many regulations inherent in their industry.
Genzyme determined that they needed to create a Global Product Data Management system that consists of many laboratory systems working together as a cohesive solution. They implemented a new Laboratory Information Management System (LIMS) and Scientific Data Management System (SDMS) to deal with the massive amounts of data being generated by their laboratory instruments, recognizing the need that these instruments and systems communicate in order to leverage their technology investment.
Genzyme chose Labtronics’ LimsLink laboratory data integration solution to provide the required communication capabilities. LimsLink can provide a bi-directional connection between all of the company’s laboratory instruments and their management systems, both LIMS and SDMS. The automation of test results downloaded from their lab instruments to their management systems enables Genzyme to eliminate human error in data entry and to increase lab productivity. LimsLink is also fully compliant with the regulations that biotechnology companies have to comply with including FDA 21 CFR Part 11.
“LimsLink is an integral part of our Global Product Management solution,” said Bennett Green, Senior Vice President of Global Quality Operations at Genzyme Corporation. “We have successfully tested and validated the complete solution in many of our labs and are now continuing to deploy the solution across additional locations around the world.”
“This was a very strategic project for Genzyme and we are honored that LimsLink was chosen as their integration standard,” said Robert Pavlis, President of Labtronics Inc. “We are looking forward to continuing to work closely with Genzyme as they roll this solution out to all of their laboratories.”
